GTBIF stock forecast incorporates sector growth drivers like increasing medical cannabis adoption, projected to expand annual industry revenue beyond $30B by 2025, which favors vertically integrated players like Green Thumb. The post 3 Cannabis Stocks Set for a High-Growth Comeback appeared first on InvestorPlace . Omor Ibne Ehsan is a writer at InvestorPlace. He is a self-taught investor with a focus on growth and cyclical stocks that have strong fundamentals, value, and long-term potential. He also has an interest in high-risk, high-reward investments such as cryptocurrencies and penny stocks. You can follow him on LinkedIn . Analysts believe GTBIF stock forecast gains credibility from the company’s diversified product portfolio and vertical integration across cultivation, manufacturing, and retail channels.